Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges.
Stasi
Roberto
R
Amadori
Sergio
S
Newland
Adrian C
AC
Provan
Drew
D
D000740:Anemia / Q000150:complications; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D004921:Erythropoietin / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D010919:Placebos; D011788:Quality of Life; D011994:Recombinant Proteins; D012306:Risk; D016896:Treatment Outcome
D010919:Placebos; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor